Thyroid papillary microcarcinoma
Conditions
Interventions
Active surveillance group(AS):Patients have regular follow-up appointments, and if the condition worsens or if the patient desires, surgery can be performed.
moxibustion+ AS group:Besides active surveillance, patients will receive moxibustion therapy twice a week for 10 minutes each site, over a period of 8 consecutive weeks, administered by the same thera
Sponsors
Affiliated Hospital of Jiangnan University
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18-55 years old; 2. Ultrsound test confirms it to be non-invasive subtype of DTC; 3. The maximum diameter of the mass is less than 1cm, no evidence of extra-thyroidal invasion or distant metastasis; 4. The tumor locates far from important organs, such as the recurrent laryngeal nerve and trachea; 5. No history of thyroid surgery; 6. No history of malignant tumor; 7. Accept AS.
Exclusion criteria
Exclusion criteria: 1. With elevated thyroid-related antibody levels; 2. Hyporthyroidism or hyperthyroidism; 3. Patients are taking anti-thyroid medications or thyroid hormone replacement therapy; 4. With severe cardiovascular, liver, kidney or haematological diseases; 5. With mental disorders; 6. Pregnant or lactation 7. Afraid of moxibustion or having skin diseases at the moxibustion site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the percentage of patients who fullfil active surveillance; | — |
Secondary
| Measure | Time frame |
|---|---|
| the score of anxiety or depression;tumour growth or reduction;changes of the levels of TSH; | — |
Countries
China
Contacts
Public ContactDongdong Chen
Affiliated Hospital of Jiangnan University
Outcome results
None listed